IA | II | III | IB | |
---|---|---|---|---|
N | 48 | 115 | 19 | 168 |
Age (years)* | 36.7 ± 4.8 | 37.5 ± 5.3 | 36.2 ± 6.6 | 38.3 ± 5.2 |
FSH (mIU/mL)** | 6.5 ± 1.1 | 15.1 ± 12.8 | 6.6 ±. 9.0 | 23.0 ± 21.3 |
AMH (ng/mL)** | 3.42 ± 0.8 | 2.7 ± 3.0 | 0.6 ± 0.5 | 0.5 ± 0.4 |
Oocytes (n)** | 13.1 ± 7.6 | 10.9 ± 7.3 | 9.1 ± 8.2 | 5.9 ± 5.2 |
Race: n (%) | ||||
African America | 10(18.5%) | 16(29.6%) | 2(3.7%) | 26(48.1%) |
Asian | 11(19.6%) | 21(37.5%) | 3(5.4%) | 21(37.5%) |
Caucasian | 25(11.5%) | 72(33.0%) | 11(5.0%) | 110(50.5%) |
Middle Eastern | 2(9.1%) | 6(27.3%) | 3(13.6%) | 11(50.0%) |
Primary Infertility Diagnoses: n (%)*** | ||||
DOR | 14(9.0%) | 44(28.2%) | 6(3.8%) | 92(59.0%) |
Endometriosis | 2(10.5%) | 5(26.3%) | 1(5.3%) | 11(57.9%) |
Male | 12(12.1%) | 37(37.4%) | 7(7.1%) | 43(43.4%) |
Other | 2(10.5%) | 9(47.4%) | 2(10.5%) | 6(31.6%) |
PCO | 8(36.4%) | 9(40.9%) | (0.0%) | 5(22.7%) |
Tubal | 10(30.3%) | 10(30.3%) | 3(9.1%) | 10(30.3%) |
Uterine | 0(0.0%) | 1(50.0%) | 0(0.0%) | 1(50.0%) |